Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 798 results for "lymphocyte count"

Lack of an Association between Neutrophil-to-Lymphocyte Ratio ...

Introduction. The neutrophil-to-lymphocyte ratio (NLR), which can be easily calculated from routine complete blood counts of the peripheral blood, has been suggested to serve as a prognostic factor for some solid malignancies. In the present study, ... UroToday, 2 days ago
[x]  
Examiner.com

Characteristics of chronic lymphocytic leukemia in Senegal

Chronic lymphocytic leukaemia (CLL) is the most common form of leukaemia in Western countries 1], 2] while it is extremely rare in Africa 10], 11]. In 3years, only 40 patients with CLL were identified in several centers of Senegal with an average ...
 HealthMediciNet.com1 month ago New drug approved for chronic lymphocytic leukemia  Examiner.com1 month ago AbbVie/Roche's Venclexta produces complete remission in 10% of hard-to-treat CLL patients  pharmaphorum1 week ago Inside the development of Venclexta, AbbVie's new leukemia drug  BioPharma Dive1 month ago
[x]  
European Pharmaceutical Review

Roche announces positive results from Gazyva/Gazyvaro phase III GALLIUM study in previously untreated follicular lymphoma

Roche announced positive results from the pivotal phase III GALLIUM study in people with previously untreated follicular lymphoma, the most common type of indolent (slow-growing) non-Hodgkin lymphoma (iNHL). The study compared the efficacy and ...
 PharmaBiz21 hours ago Positive results from Phase III study of Gazyva in follicular lymphoma  European Pharmaceutical Review1 day ago US FDA grants accelerated approval to Roche's Venclexta for people with hard-to-treat type of chronic lymphocytic leukemia  PharmaBiz1 month ago Roche announces FDA grants Venclexta(venetoclax) accelerated approval for people with hard-to-treat type of chronic lymphocytic leukemia  Pharmacy Choice1 month ago
[x]  
Bidness Etc

Don't Count Out Gilead's Oncology Portfolio Just Yet

A great heap of analysis has been spent on Gilead Sciences (NASDAQ: GILD ) following its numerous pieces of bad news in 2016. Perhaps most notably was the stoppage of six trials containing its flagship leukemia drug idelalisib on the basis of ...
 Seeking Alpha1 day ago Merrill Lynch Bearish on Gilead Sciences, Inc. Despite Trivial Merck Damages  Bidness Etc1 month ago

Hemophagocytic Lymphohistiocytosis With Cerebral Involvement in Richter's Syndrome [DIAGNOSIS IN ONCOLOGY]

Case Report A 69-year-old man presented with a several week history of progressive cerebellar ataxia and myoclonia. His past medical history included hypertension and a resected prostatic neoplasm, considered to be in remission. Except for the ...
 Journal of Clinical Oncology5 days ago Ventriculitis Caused by Primary T-Cell CNS Lymphoma in an Immunocompetent Patient [DIAGNOSIS IN ONCOLOGY]  Journal of Clinical Oncology2 weeks ago Diffused Pulmonary Infiltrates With T-Cell Large Granular Lymphocytic Leukemia  CHEST3 weeks ago Loxoprofen-induced interstitial pneumonia: a case report  HealthMediciNet.com3 days ago
Minyanville

U.S. FDA Expands IMBRUVICA® (ibrutinib) Label to Include Overall Survival Data in Previously Untreated Chronic Lymphocytic Leukemia (CLL) and New Indication for Small Lymphocytic Lymphoma (SLL) Patients

NORTH CHICAGO, Ill., May 9, 2016 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) updated the IMBRUVICA (ibrutinib) Prescribing Information (PI) to include new data ...
 Bloomberg2 weeks ago U.S. FDA Expands IMBRUVICA(R) (ibrutinib) Label to Include Overall Survival Data in Previously Untreated Chronic Lymphocytic Leukemia (CLL) and New Indication for Small Lymphocytic Lymphoma (SLL) Patients  Healthcare Sales & Marketing Network2 weeks ago Biogen and AbbVie Receive FDA Approval of Once-Monthly ZINBRYTA (Daclizumab) for Multiple Sclerosis  Minyanville1 day ago BIOGEN : and AbbVie Receive FDA Approval of Once-Monthly ZINBRYTA(TM) (daclizumab) for Multiple Sclerosis  4 Traders1 day ago
[x]  
Broadway World

Local Book Author, Max Kopsho, Pledges 50% Profits to Leukaemia Lymphoma Society

Max Kopsho author of the Art and Science of The Art and Science of Da Vinci Sales: The 7 Keys to Selling Leonardo, award winning technical industry trainer, sales guru and Sugar Hill, GA resident launches a new type of sales development book and ...
 Broadway World1 month ago Local Book Author Pledges 50% Profits to Leukaemia Lymphoma Society April 25, 2016Max Kopsho, author of The Art and Science of Da Vinci Sales: The 7 Keys to Selling Like Leonardo, award winning technical industry trainer, sales guru and Sugar Hill, GA res  PRWeb1 month ago

Lymphocyte subpopulations in premature infants: an observational study

Abstract Background and objectives The infant's immune system evolves over the first months and years of life. Strong correlation exists between lymphocyte count, lymphocyte subpopulations and gestational age at birth. Associations with antenatal ...
 ADC Fetal and Neonatal1 month ago

Novel Biochip Combines Antibody Binding and Electronic Counting to Simplify Diagnosis of HIV/AIDS

Image: Close-up of the differential immuno-capture biochip (Photo courtesy of Dr. Umer Hassan, University of Illinois). A recent paper described the construction of a microchip biosensor that uses immuno-capture technology to detect ...
 Lab Medica2 months ago

Annals for Educators - 17 May 2016

The most likely diagnosis for this patient, who presents with fever, lymphocytic meningitis, and petechial rash following tick exposure, is Rocky Mountain spotted fever (RMSF). Headache is common in RMSF, and meningoencephalitis is seen in as many ...
 Annals of Internal Medicine1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less